Can-Fite BioPharma Ltd. (CANF)
3.35
+0.02
(+0.60%)
USD |
NYAM |
Aug 24, 16:00
3.28
-0.07
(-2.09%)
After-Hours: 20:00
Can-Fite BioPharma Market Cap : 4.390M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 4.390M |
| August 21, 2026 | 4.364M |
| August 20, 2026 | 4.390M |
| August 19, 2026 | 4.560M |
| August 18, 2026 | 4.521M |
| August 17, 2026 | 4.692M |
| August 14, 2026 | 4.456M |
| August 13, 2026 | 4.456M |
| August 12, 2026 | 4.508M |
| August 11, 2026 | 4.338M |
| August 10, 2026 | 4.207M |
| August 07, 2026 | 4.508M |
| August 06, 2026 | 4.665M |
| August 05, 2026 | 4.194M |
| August 04, 2026 | 4.180M |
| August 03, 2026 | 4.154M |
| July 31, 2026 | 4.128M |
| July 30, 2026 | 4.298M |
| July 29, 2026 | 4.194M |
| July 28, 2026 | 4.141M |
| July 27, 2026 | 4.128M |
| July 24, 2026 | 4.180M |
| July 23, 2026 | 4.233M |
| July 22, 2026 | 4.325M |
| July 21, 2026 | 4.430M |
| Date | Value |
|---|---|
| July 20, 2026 | 4.338M |
| July 17, 2026 | 4.456M |
| July 16, 2026 | 4.351M |
| July 15, 2026 | 4.298M |
| July 14, 2026 | 4.220M |
| July 13, 2026 | 4.272M |
| July 10, 2026 | 4.259M |
| July 09, 2026 | 4.285M |
| July 08, 2026 | 4.259M |
| July 07, 2026 | 4.560M |
| July 06, 2026 | 4.980M |
| July 02, 2026 | 5.124M |
| July 01, 2026 | 6.068M |
| June 30, 2026 | 3.892M |
| June 29, 2026 | 3.827M |
| June 26, 2026 | 3.604M |
| June 25, 2026 | 3.853M |
| June 24, 2026 | 3.918M |
| June 23, 2026 | 3.997M |
| June 22, 2026 | 4.010M |
| June 18, 2026 | 3.905M |
| June 17, 2026 | 3.971M |
| June 16, 2026 | 3.932M |
| June 15, 2026 | 3.918M |
| June 12, 2026 | 3.722M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioLineRx Ltd. | 13.05M |
| XTL Biopharmaceuticals Ltd. | 6.210M |
| Kamada Ltd. | 486.36M |
| Galmed Pharmaceuticals Ltd. | 3.341M |
| Revium Recovery, Inc. | 86.84M |
Market Cap Related Metrics
| PS Ratio | 7.719 |
| Price to Book Value | 2.432 |
| Price | 3.35 |
| Earnings Yield | -371.6% |